GlobalPost |
UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters Xolair is an injectible drug that was originally approved in 2003 to treat moderate to severe asthma in adults and children aged 12 or over whose condition was not controlled by inhaled steroids. The drug is also approved to treat chronic idiopathic … FDA says asthma drug Xolair raises risk of heart, brain problems FDA warns of increased risks of asthma drug Xolair FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events |
View full post on asthma – Google News